EGFR and non-small cell lung carcinoma: Although the number of patients in this study was limited, together these results demonstrate that 18F-IRS is a valuable PET probe for the specific detection of tumors bearing EGFR-activating mutations and as a guide for personalized therapy in NSCLC.